Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Bostal Drug Delivery is a specialized pharmaceutical company focused on the research, development, and industrialization of high-end drug delivery systems. Based in Guangzhou, China, the company leverages its expertise in the 505(b)(2) regulatory pathway to create value-added medicines with improved safety and efficacy profiles. Their core technology platforms include long-acting injectables, oral sustained-release formulations, and complex solubilization techniques such as hot-melt extrusion and microsphere encapsulation. Bostal's pipeline primarily targets central nervous system disorders, cardiovascular diseases, and chronic pain management. As a key subsidiary of Boji Medical, the company provides integrated R&D and CDMO services for complex drug products to global partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Bostal Drug Delivery.